Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced recently that in its longest study yet on tirzepatide, the drug reduced the risk of people with prediabetes moving on to develop diabetes by 94% compared to those taking a placebo.

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.

The success of weight-loss injections has prompted pharmaceutical companies to produce a next-generation anti-obesity pill

Ozempic and similar weight-loss drugs can lower the risk of heart attack, stroke, kidney and liver disease, and even increase fertility Ozempic, first approved in China to treat diabetes in 2021, is often referred to as the "internet celebrity weight-loss drug".

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in recent years.

A study has found that despite its popularity, Ozempic isn’t actually the most effective weight loss drug out there. Ozempic, which was originally designed as a treatment for people with type 2 diabetes,